Abstract
Whilst Technetium-Ida derivatives all show basically similar patterns of biodistribution and as such are suited for cholescintigraphy they nevertheless differ significantly enough from each other to have warranted more detailed comparisons to select the reagent most suited for cholescintigraphy in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Loberg MD et al, Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. J. nucl. Med. 17: 633, 1976.
Ryan J et al, Technetium-99m-labelled N (216-dimethylcarbamoyl methyl) iminodiacetic acid: A new radiopharmaceutical for hepatobiliary imaging studies. J. nucl. Med. 17: 545, 1977.
Chiotellis E et al, 99mTc-Hida a gall-bladder imaging agent. Experimental aspects. Eur. J. nucl. Med. 3:41, 1978.
Wistow BW et al, An evaluation of 99mTc-hepatobiliary imaging agents. J. nucl. Med. 18: 455, 1977.
Smith RB et al, Pharmacokinetics of hepatobiliary imaging agents in rats. J. nucl. Med. 20: 45, 1979.
Subramanian G et al, The influence of structural changes on biodistribution of 99mTc N-substituted Ida derivatives. In: Nuklearmedizin. Proceedings 15th International Congress Society of Nuclear Medicine (Europe). Schmidt HAE, Woldring MG (eds), Groningen, 1977.
Zivanovic M et al, The stability and distribution of Tc-Hida in vivo and in vitro. Eur. J. nucl. Med. 4: 369, 1979.
Cox PH, The comparative pharmacology of technetium ida derivatives. In: Progress in Radiopharmacology. Vol.l. Cox PH (ed), Amsterdam, Elsevier/ North-Holland Biomedical Press, 1979.
Burns D et al, Relationship between molecular structure and biliary excretion of Tc99m Hida and Hida analogues. J. nucl. Med. 18: 624, 1977.
Chiotellis E, Varvarigou A, 99mTc labelled N-substituted carbamoyl iminodiacetates: Relationship between structure and distribution. Int. J. nucl. Med. Biol. 7: 1, 1980.
Tjen HSLM, Cholescintigraphy. Ph.D. Thesis, University of Utrecht, The Netherlands (in English ), 1979.
Harvey E et al, Hepatic clearance mechanism of Tc99m Hida and its effect on quantitation of hepato biliary function: consise communication. J. nucl. Med. 20: 310, 1979.
Kitani K et al, Inhibiting effect of sulphobromophthalein (BSP) on the hepatic uptake and biliary excretion of 99mTc Hida in rats. Jap. J. nucl. Med. 15: 999, 1978.
Kitani K et al, Inhibiting effect of sulphobromophthalein on the hepatic uptake and biliary excretion of 99mTc-N (2.6 dimethylphenylcarbamoylmethyl) diacetic acid and pyridoxylene isoluceine in rats. J. nucl. Med. 20: 642, 1979.
Porter DW et al, Comparison of hepatobiliary radiopharmaceuticals in an in vitro model. J. nucl. Med. 20: 642, 1979.
Fritzberg AR et al, Hepatobiliary mechanism of Tc99m-N (2.6 diethylacetanilido)iminodiacarboxylic acid (Diethylida). J. nucl. Med. 20: 642, 1979.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Cox, P.H. (1981). The Radiopharmacological Behaviour of Ida-Derivatives in Normal Experimental Animals. In: Cox, P.H. (eds) Cholescintigraphy. Developments in Nuclear Medicine, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8325-0_4
Download citation
DOI: https://doi.org/10.1007/978-94-009-8325-0_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8327-4
Online ISBN: 978-94-009-8325-0
eBook Packages: Springer Book Archive